Are methods for estimating QALYs in cost-effectiveness analyses improving?

被引:58
作者
Neumann, PJ
Zinner, DE
Wright, JC
机构
[1] COVANCE HLTH ECON & OUTCOMES SERV INC, WASHINGTON, DC USA
[2] HARVARD UNIV, JOHN F KENNEDY SCH GOVT, CAMBRIDGE, MA 02138 USA
关键词
QALYs; quality-adjusted; cost-effectiveness analysis;
D O I
10.1177/0272989X9701700405
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives. The objectives of this study were to examine variations in the methods used by researchers to estimate QALYs in published cost-effectiveness analyses, and to investigate whether the methods have improved over time. Data and methods. Using a MEDLINE search, the authors identified 86 original cost-effectiveness analyses, published between 1975 and 1995, that used QALYs as the measure of effectiveness. For each study, they recorded the health-state classification system, the source of the preference weights, the measurement technique, and the discount rate. The methods used were compared with the recommendations of the U.S. Panel on Cost-Effectiveness in Health and Medicine. Results. Only 20% of the studies used ''generic'' health-state classification systems (e.g., health utilities index); 21% relied on community-based weights; 40% used formal measurement techniques (e.g., time-tradeoff method); and 88% discounted both future costs and QALYs. There was little evidence that methods had improved over time. Conclusions. The results illustrate extensive variation in the construction of QALYs in cost-effectiveness analyses and reveal that most studies have not adhered to practices now recommended by leaders in the field. There is a need for more methodologic rigor and consistency if the results of such studies are to be compared and used for purposes of allocating resources.
引用
收藏
页码:402 / 408
页数:7
相关论文
共 24 条
[1]  
BURROWS C, 1993, AUST J PUBLIC HEALTH, V17, P278
[2]   SHOULD QALYS BE PROGRAM-SPECIFIC [J].
DONALDSON, C ;
ATKINSON, A ;
BOND, J ;
WRIGHT, K .
JOURNAL OF HEALTH ECONOMICS, 1988, 7 (03) :239-257
[3]  
Drummond M, 1993, Int J Technol Assess Health Care, V9, P26
[4]   COST-EFFECTIVENESS LEAGUE TABLES - MORE HARM THAN GOOD [J].
DRUMMOND, M ;
TORRANCE, G ;
MASON, J .
SOCIAL SCIENCE & MEDICINE, 1993, 37 (01) :33-40
[5]  
Drummond M, 1987, METHODS EC EVALUATIO
[6]   MULTIATTRIBUTE HEALTH-STATUS CLASSIFICATION SYSTEMS - HEALTH UTILITIES INDEX [J].
FEENY, D ;
FURLONG, W ;
BOYLE, M ;
TORRANCE, GW .
PHARMACOECONOMICS, 1995, 7 (06) :490-502
[7]   QALYS, HYES, AND THE LOSS OF INNOCENCE [J].
FRYBACK, DG .
MEDICAL DECISION MAKING, 1993, 13 (04) :271-272
[8]   A NEW END-POINT FOR THE ASSESSMENT OF ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH OPERABLE BREAST-CANCER [J].
GELBER, RD ;
GOLDHIRSCH, A .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) :1772-1779
[9]   COST-UTILITY IN PRACTICE - A POLICY MAKERS GUIDE TO THE STATE-OF-THE-ART [J].
GERARD, K .
HEALTH POLICY, 1992, 21 (03) :249-279
[10]  
Gold MR., 1996, COST EFFECTIVENESS H